Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-28 02:32:05 - browse：468

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： White House touts steps to stem shortages of cancer treatments

hotspot

WSS

White House touts steps to stem shortages of cancer treatments

What to expect at HLTH 2023, the health care industry conference

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Will the IRA bring competition to the biologics market?

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Bristol 'take

entertainment

Wikipedia

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Walmart eyes Medicare Advantage provider ChenMed

Sports medicine is finally prioritizing gender equality

White House touts steps to stem shortages of cancer treatments

Alkermes shareholders re

Bill would stop addiction treatment from triggering child abuse inquiry

The high cost of giving birth even with insurance

Walmart eyes Medicare Advantage provider ChenMed

Guidelines to prevent youth baseball injuries need more muscle

Chan Zuckerberg Biohub Chicago to focus on inflammation

leisure time

Bill would stop addiction treatment from triggering child abuse inquiry

Acelyrin, a rare IPO success, stumbles in its first big test

FDA proposes changes to key medical devices approval pathway

VC firm General Catalyst wants to buy a health system

FDA panel signals lack of confidence in Amgen cancer drug data

Bristol 'take

hotspot

hotspot

hotspot

hotspot